Big money planting seeds in healthcare.
Looking at TEVA's chart, showing signs of promise on the one year, looks pretty good on the 5 year, terrible on the all time chart.
Not much growth there, but cheap. 1.5x price to sales. 10x price to cash flow. PFE, which is also very cheap, by comparison is 2.2x and 7.8x respectively. LLY at 13x and 28x.
No Div though for Teva. Almost 7% for PFE.